Executive Summary
The 50 filings for the 'USA Insider Trading Pulse' stream (single-day window 2026-11-03) are dominated by routine Form 4 activity: director and officer equity grants, tax-withholding dispositions on vesting RSUs, and a smaller set of open-market purchases and sales.
Insider buying is concentrated in a few names (ProMIS Neurosciences, STARZ, Taiwan Semiconductor, Constellium, First Financial Bankshares, Caterpillar, and a 10% holder in John Hancock GA Senior Loan Trust), which is the most informative signal in the set. Insider selling is limited and clustered in a handful of issuers (Vicor, Crocs, Labcorp, Hyatt, Cullen/Frost, eBay), with several sales explicitly executed under Rule 10b5-1 plans, which lowers their informational value. The enriched period-over-period, guidance, and capital allocation fields are largely absent from these Form 4 filings, so trend and guidance analysis is limited; conclusions rest on transaction size, direction, and post-trade holdings. Overall the tape reads as neutral: grant-driven flows dominate, with modest open-market conviction in small-cap biotech and a few financials.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Form 4
Tracking the trend? Catch up on the prior USA Insider Trading Pulse digest from November 02, 2026.
Investment Signals (12)
- ProMIS Neurosciences ↓ (BULLISH)▲
Chief Scientific Officer Cashman Neil bought 10,000 shares at $3.86 (~$38.6K), raising holdings to 14,532; director Williams Eugene bought 1,316 shares at $3.99 (~$5.25K)
- Caterpillar ↓ (BULLISH)▲
Director Fish James C Jr bought 1,000 shares at $620.39 (~$620K), a meaningful open-market purchase by an outside director, holding 4,714 shares
- Taiwan Semiconductor (2330.TW) (BULLISH)▲
VP Yuan Lipen bought 1,000 shares at $71.49 (~$71.5K), bringing holdings to 8,000 shares
- STARZ Entertainment ↓ (BULLISH)▲
President and CEO Hirsch Jeffrey bought 5,000 shares at $22.13 (~$111K), now holding 70,000 shares; SVP-level director Kapenstein James M. also bought 460 shares at $22.84 (~$10.5K)
- First Financial Bankshares ↓ (BULLISH)▲
Director Edwards Murray Hamilton bought 800 shares across two trades (300 at $30.56, 500 at $30.51; ~$24.5K total), holding 45,434 shares
- Constellium SE ↓ (BULLISH)▲
Director Deslarzes Jean-Christophe bought 1,800 shares at $23.41 (~$42.1K), lifting holdings to 45,315 shares
- John Hancock GA Senior Loan Trust ↓ (BULLISH)▲
10% owner Manufacturers Life Insurance (Bermuda Branch) bought 756,629 shares at $16.12 (~$12.2M), now holding ~21.6M units
- Vicor Corp ↓ (BEARISH)▲
VP-Global Sales & Mktg. Davies Philip D sold 478 shares at $175.00 (~$83.6K) and 100 at $176.26 under a 10b5-1 plan, after exercising 3,073 options; holdings fall to 1,920 shares
- Crocs, Inc. ↓ (BEARISH)▲
Director Frasch Ronald sold 15,000 shares at $153.51 (~$2.3M), leaving 61,180 shares; EVP Campbell Rupert George sold 2,645 shares at $150.87 (~$399K)
- Hyatt Hotels ↓ (BEARISH)▲
KLP 2006-N3 Family Trust sold 32,182 Class B shares at $186.57 (~$6.0M) and 28,820 at $187.58 (~$5.41M), roughly $11.4M in aggregate
- Labcorp Holdings ↓ (BEARISH)▲
Director Parham Richelle P sold 1,078 shares at $361.22 (~$389K), reducing holdings to 2,288 shares
- Cullen/Frost Bankers ↓ (BEARISH)▲
Chief Accounting Officer Henson Matthew Bradley sold 534 shares at $159.72 (~$85.3K), leaving 317 shares, a near-complete reduction in direct holdings
Risk Flags (8)
- Crocs, Inc./Insider Selling↓ [MEDIUM RISK]▼
Two insiders sold in the same filing window (director Frasch ~$2.3M; EVP Campbell ~$399K), a cluster that warrants monitoring for pattern continuation
- Hyatt Hotels/Concentrated Holder Exit↓ [MEDIUM RISK]▼
A single family trust sold ~$11.4M across two blocks at prices within ~$1 of each other, suggesting a deliberate large-holder distribution rather than routine compensation-related selling
- Cullen/Frost Bankers/Near-Full Exit↓ [MEDIUM RISK]▼
CAO Henson sold 534 shares and retains only 317, a 62% reduction in holdings by one officer, which is a notable conviction signal even at modest dollar size
- Vicor Corp/Option-Exercise Selling↓ [LOW-MEDIUM RISK]▼
VP Davies exercised 3,073 options and sold proceeds, cutting holdings to 1,920 shares; sales are under a 10b5-1 plan, so intent is less clear but the post-trade position is thin
- Labcorp Holdings/Director Reduction↓ [LOW-MEDIUM RISK]▼
Director Parham sold 1,078 shares (~$389K), reducing to 2,288 shares, a meaningful proportional cut for a board member
- Northrop Grumman/Director Selling↓ [LOW RISK]▼
Director Welsh Mark A III sold ~100 shares across five transactions at ~$553–556 under a 10b5-1 plan; small dollar amount but a repeated pattern
- Nordson Corp/Tax-Withholding Volume↓ [LOW RISK]▼
Multiple officers withheld shares for taxes (Kelley ~$478K, Subramanian ~$191K), which is non-discretionary but represents heavy vesting; worth noting alongside 10+ director grants on the same date
- Ribbon Communications/Vesting Dispositions↓ [LOW RISK]▼
EVP McCaffery withheld 50,762 shares for taxes on a large vesting event (~$78.7K withheld) after exercising 144,009 shares, a substantial pre-tax share-count change
Opportunities (7)
- ProMIS Neurosciences/Insider Accumulation↓ (OPPORTUNITY)◆
Two insiders (CSO and a director) bought in the same window, totaling roughly $44K, a cluster of open-market buying in a micro-cap biotech often read as management conviction ahead of catalysts
- Caterpillar/Outside Director Conviction↓ (OPPORTUNITY)◆
A ~$620K purchase by an independent director at $620.39 is a sizable open-market buy by a non-executive, a higher-quality signal than compensation-driven flows
- ◆
Manufacturers Life added ~756,629 units (~$12.2M) at $16.12 as a 10% holder, signaling sponsor-level support for the vehicle
- STARZ Entertainment/CEO Purchase↓ (OPPORTUNITY)◆
CEO Hirsch's $111K open-market buy at $22.13 is the largest executive purchase among the consumer/media names and comes alongside a smaller director buy, a constructive insider signal
- ◆
VP Yuan's ~$71.5K purchase in a large-cap semiconductor name is a relatively rare open-market buy by an executive at a mega-cap, worth tracking alongside sector sentiment
- ◆
Director Edwards bought in two tranches at nearly identical prices (~$30.5), a disciplined accumulation pattern in a regional bank
- Constellium/Director Buy↓ (OPPORTUNITY)◆
Director Deslarzes' ~$42K purchase at $23.41 adds to an existing ~45K-share position, a conviction-add signal from a board member
Sector Themes (6)
- Grant-Driven Insider Flows Dominate◆
Roughly 20 of 50 filings are director or officer equity awards (RSUs, restricted stock, phantom units, options), with the Nordson and Friedman Industries director grant batches the largest examples; these carry little directional information about insider sentiment
- Tax-Withholding Dispositions Are Non-Discretionary◆
At least 10 filings (Nordson, Labcorp, Prudential, Clean Harbors, Ribbon, Forgent-adjacent vesting events) show shares withheld for taxes on vesting; these should be netted out before reading insider sell-side conviction
- Open-Market Buying Concentrated in Small/Mid Caps and Financials◆
Meaningful buys are clustered in micro-cap biotech (ProMIS), regional banking (First Financial), and mid-cap industrials/media (Caterpillar, STARZ), while large-cap selling concentrates in healthcare services and consumer names
- Rule 10b5-1 Plans Common Among Sellers◆
At least five sale filings (Northrop, Vicor, Nordson/Morris, UFP, and others) cite 10b5-1 plans, implying pre-scheduled sales that carry lower signal value than discretionary sales like Cullen/Frost's and Labcorp's
- Financial Sector Mixed Signals◆
Financials show both buying (First Financial, Constellium-adjacent, the Manufacturers Life trust) and selling (Cullen/Frost CAO, Hyatt family trust), with no clear directional consensus
- Limited Forward-Looking and Capital-Allocation Data◆
Form 4 filings in this set contain no guidance, dividend, or buyback disclosures, so period-over-period and capital allocation analysis could not be performed; investment conclusions here are insider-flow based only
Watch List (7)
-
Two insider purchases in a single window (CSO ~$38.6K, director ~$5.25K); monitor for further open-market buying ahead of any clinical or financing updates
-
Director and EVP sales (~$2.3M and ~$399K) in the same filing window; watch for additional insider sales as a pattern or a 10b5-1 cadence signal
-
KLP 2006-N3 Family Trust sales (~$11.4M across two blocks) suggest continued distribution by a concentrated holder; monitor further Form 4 filings from the trust
-
Director Fish's ~$620K purchase is among the larger outside-director buys in the set; watch whether other directors follow
-
CAO Henson now holds only 317 shares after selling 534; monitor for further reductions or a departure-related filing
-
Manufacturers Life's continued accumulation as a 10% holder (~21.6M units) warrants tracking for any further block purchases or changes in sponsor position
-
VP Davies' option exercises and 10b5-1 sales leave a thin post-trade position (1,920 shares); monitor for any further exercises or plan-driven sales
Filing Analyses
(50)
03-11-2026
Director Potts Charles Edward was awarded 1,034 Grants.
- · Director Potts Charles Edward was awarded 1,034 Grants
03-11-2026
Director Rowe Zane was awarded 222 Common Stock. Rowe Zane holds 13,466 shares after the transaction.
- · Director Rowe Zane was awarded 222 Common Stock
03-11-2026
Director TRAQUINA PERRY M was awarded 253 Common Stock. TRAQUINA PERRY M holds 89,355 shares after the transaction.
- · Director TRAQUINA PERRY M was awarded 253 Common Stock
03-11-2026
Director Chennapragada Aparna was awarded 185 Common Stock. Chennapragada Aparna holds 18,492 shares after the transaction.
- · Director Chennapragada Aparna was awarded 185 Common Stock
03-11-2026
SEE REMARKS Kapenstein James M. bought 460 Common Shares at $22.84 (~$10.5K). Kapenstein James M. holds 12,762 shares after the transaction.
- · SEE REMARKS Kapenstein James M. bought 460 Common Shares at $22.84 (~$10.5K)
03-11-2026
VP Yuan Lipen bought 1,000 Common Shares (2330.TW) at $71.49 (~$71.5K). Yuan Lipen holds 8,000 shares after the transaction.
- · VP Yuan Lipen bought 1,000 Common Shares (2330.TW) at $71.49 (~$71.5K)
03-11-2026
Shen Ethan PhD reported beneficial ownership in SL Science Holding Ltd. No securities are beneficially owned.
03-11-2026
Director McClintock William was awarded 52 Restricted Stock Units.
- · Director McClintock William was awarded 52 Restricted Stock Units
03-11-2026
SVP, Operational Finance ZHANG ZHIHUA sold 28,740 Class A ordinary shares at $0.55 (~$15.7K). ZHANG ZHIHUA holds 84,384 shares after the transaction.
- · SVP, Operational Finance ZHANG ZHIHUA exercised/converted 79,200 Class A ordinary shares
- · SVP, Operational Finance ZHANG ZHIHUA sold 28,740 Class A ordinary shares at $0.55 (~$15.7K)
- · SVP, Operational Finance ZHANG ZHIHUA exercised/converted 79,200 Restricted Share Units (RSUs)
03-11-2026
Director Chen David Lifeng exercised/converted 83,538 Class A ordinary shares. Chen David Lifeng holds 584,790 shares after the transaction.
- · Director Chen David Lifeng exercised/converted 83,538 Class A ordinary shares
- · Director Chen David Lifeng exercised/converted 83,538 Restricted Share Units (RSUs)
03-11-2026
Executive Vice President Tang Heng was awarded 52,584,563 Class B1 ordinary share. Tang Heng holds 52,584,563 shares after the transaction.
- · Executive Vice President Tang Heng was awarded 52,584,563 Class B1 ordinary share
03-11-2026
Chief Scientific Officer Cashman Neil bought 10,000 Common Shares at $3.86 (~$38.6K). Cashman Neil holds 14,532 shares after the transaction.
- · Chief Scientific Officer Cashman Neil bought 10,000 Common Shares at $3.86 (~$38.6K)
03-11-2026
Director Williams Eugene bought 1,316 Common Shares at $3.99 (~$5.25K). Williams Eugene holds 13,713 shares after the transaction.
- · Director Williams Eugene bought 1,316 Common Shares at $3.99 (~$5.25K)
03-11-2026
VP, Chief Accounting Officer SPENCER REBECCA sold 2,366 Common Stock at $121.86 (~$288K). SPENCER REBECCA holds 9,581 shares after the transaction.
- · VP, Chief Accounting Officer SPENCER REBECCA sold 2,366 Common Stock at $121.86 (~$288K)
03-11-2026
President and CEO Hirsch Jeffrey bought 5,000 Common Shares at $22.13 (~$111K). Hirsch Jeffrey holds 70,000 shares after the transaction.
- · President and CEO Hirsch Jeffrey bought 5,000 Common Shares at $22.13 (~$111K)
03-11-2026
Director JONES GINGER M was awarded 583 NDSN at $322.67 (~$188K). JONES GINGER M holds 6,927 shares after the transaction.
- · Director JONES GINGER M was awarded 583 NDSN at $322.67 (~$188K)
03-11-2026
Executive Vice President Kelley Joseph P had withheld for taxes 1,481 NDSN at $322.67 (~$478K). Kelley Joseph P holds 5,787 shares after the transaction.
- · Executive Vice President Kelley Joseph P had withheld for taxes 1,481 NDSN at $322.67 (~$478K)
03-11-2026
Executive Vice President Subramanian Srinivas had withheld for taxes 593 NDSN at $322.67 (~$191K). Subramanian Srinivas holds 5,814 shares after the transaction.
- · Executive Vice President Subramanian Srinivas had withheld for taxes 593 NDSN at $322.67 (~$191K)
03-11-2026
Director Parmentier Jennifer A was awarded 583 NDSN at $322.67 (~$188K). Parmentier Jennifer A holds 4,897 shares after the transaction.
- · Director Parmentier Jennifer A was awarded 583 NDSN at $322.67 (~$188K)
03-11-2026
Director DeFord John A was awarded 583 NDSN at $322.67 (~$188K). DeFord John A holds 6,579 shares after the transaction.
- · Director DeFord John A was awarded 77 NDSN at $322.67 (~$24.8K)
- · Director DeFord John A was awarded 583 NDSN at $322.67 (~$188K)
03-11-2026
Director MERRIMAN MICHAEL J was awarded 583 NDSN at $322.67 (~$188K). MERRIMAN MICHAEL J holds 30,437 shares after the transaction.
- · Director MERRIMAN MICHAEL J was awarded 583 NDSN at $322.67 (~$188K)
03-11-2026
Director Morris Milton Mayo was awarded 583 NDSN at $322.67 (~$188K). Morris Milton Mayo holds 2,848 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Morris Milton Mayo was awarded 583 NDSN at $322.67 (~$188K)
03-11-2026
EVP, Global Sales McCaffery Stephen J. had withheld for taxes 50,762 Common Stock at $1.55 (~$78.7K). 6 transactions reported in total. McCaffery Stephen J. holds 163,526 shares after the transaction.
- · EVP, Global Sales McCaffery Stephen J. exercised/converted 36,003 Common Stock
- · EVP, Global Sales McCaffery Stephen J. had withheld for taxes 16,921 Common Stock at $1.55 (~$26.2K)
- · EVP, Global Sales McCaffery Stephen J. exercised/converted 108,006 Common Stock
- · EVP, Global Sales McCaffery Stephen J. had withheld for taxes 50,762 Common Stock at $1.55 (~$78.7K)
- · EVP, Global Sales McCaffery Stephen J. exercised/converted 36,003 Restructed Stock Unites (RSUs)
- · EVP, Global Sales McCaffery Stephen J. exercised/converted 108,006 RSUs
03-11-2026
Director Deslarzes Jean-Christophe bought 1,800 Ordinary shares at $23.41 (~$42.1K). Deslarzes Jean-Christophe holds 45,315 shares after the transaction.
- · Director Deslarzes Jean-Christophe bought 1,800 Ordinary shares at $23.41 (~$42.1K)
03-11-2026
Director MAPES CHRISTOPHER L was awarded 583 NDSN at $322.67 (~$188K). MAPES CHRISTOPHER L holds 3,660 shares after the transaction.
- · Director MAPES CHRISTOPHER L was awarded 43 NDSN at $322.67 (~$13.9K)
- · Director MAPES CHRISTOPHER L was awarded 583 NDSN at $322.67 (~$188K)
03-11-2026
EVP, Industrial Services Geer Charles H. II had withheld for taxes 294 Common Stock at $302.12 (~$88.8K). Geer Charles H. II holds 10,505 shares after the transaction.
- · EVP, Industrial Services Geer Charles H. II had withheld for taxes 294 Common Stock at $302.12 (~$88.8K)
03-11-2026
Director Scott Sandra Kay was awarded 238 Common Stock. Scott Sandra Kay holds 10,807 shares after the transaction.
- · Director Scott Sandra Kay was awarded 238 Common Stock
03-11-2026
Director Taylor Sharon L was awarded 238 Common Stock. Taylor Sharon L holds 8,107 shares after the transaction.
- · Director Taylor Sharon L was awarded 238 Common Stock
03-11-2026
Chief Accounting Officer Henson Matthew Bradley sold 534 Common Stock, $0.01 par value at $159.72 (~$85.3K). Henson Matthew Bradley holds 317 shares after the transaction.
- · Chief Accounting Officer Henson Matthew Bradley sold 534 Common Stock, $0.01 par value at $159.72 (~$85.3K)
03-11-2026
KLP 2006-N3 Family Trust sold 32,182 Class B Common Stock at $186.57 (~$6M).
- · KLP 2006-N3 Family Trust sold 32,182 Class B Common Stock at $186.57 (~$6M)
- · KLP 2006-N3 Family Trust sold 28,820 Class B Common Stock at $187.58 (~$5.41M)
03-11-2026
Director Parham Richelle P sold 1,078 Common Stock at $361.22 (~$389K). Parham Richelle P holds 2,288 shares after the transaction.
- · Director Parham Richelle P sold 1,078 Common Stock at $361.22 (~$389K)
03-11-2026
EVP, CIO & CTO Oyegunwa Akinbolade had withheld for taxes 118 Common Stock at $355.59 (~$42K). Oyegunwa Akinbolade holds 5,316.253 shares after the transaction.
- · EVP, CIO & CTO Oyegunwa Akinbolade exercised/converted 370 Common Stock
- · EVP, CIO & CTO Oyegunwa Akinbolade had withheld for taxes 118 Common Stock at $355.59 (~$42K)
- · EVP, CIO & CTO Oyegunwa Akinbolade exercised/converted 370 Restricted Stock Unit
03-11-2026
EVP and President, Diagnostics Vaughn Bryan T had withheld for taxes 194 Common Stock at $355.59 (~$69K). Vaughn Bryan T holds 7,150.9105 shares after the transaction.
- · EVP and President, Diagnostics Vaughn Bryan T exercised/converted 500 Common Stock
- · EVP and President, Diagnostics Vaughn Bryan T had withheld for taxes 194 Common Stock at $355.59 (~$69K)
- · EVP and President, Diagnostics Vaughn Bryan T exercised/converted 500 Restricted Stock Unit
03-11-2026
Executive Vice President Waldeck George P Jr. had withheld for taxes 823 Common Stock at $116.45 (~$95.8K). Waldeck George P Jr. holds 70,784 shares after the transaction.
- · Executive Vice President Waldeck George P Jr. exercised/converted 1,774 Common Stock
- · Executive Vice President Waldeck George P Jr. had withheld for taxes 823 Common Stock at $116.45 (~$95.8K)
- · Executive Vice President Waldeck George P Jr. exercised/converted 1,774 10/10/2023 Restricted Stock Units
03-11-2026
Director COMER JAMES F exercised/converted 5,000 Stock Appreciation Rights.
- · Director COMER JAMES F exercised/converted 5,000 Stock Appreciation Rights
- · Director COMER JAMES F exercised/converted 5,000 Non-qualified Stock Option
03-11-2026
Director WILLIAMS JOE L was awarded 238 Common Stock. WILLIAMS JOE L holds 32,940 shares after the transaction.
- · Director WILLIAMS JOE L was awarded 238 Common Stock
03-11-2026
Director Reichenthal Max Alan was awarded 238 Common Stock. Reichenthal Max Alan holds 34,127 shares after the transaction.
- · Director Reichenthal Max Alan was awarded 238 Common Stock
03-11-2026
Director WELSH MARK A III sold 50 Common Stock at $556.47 (~$27.8K). 5 transactions reported in total. WELSH MARK A III holds 4,314 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director WELSH MARK A III sold 7 Common Stock at $553.39 (~$3.87K)
- · Director WELSH MARK A III sold 20 Common Stock at $554.48 (~$11.1K)
- · Director WELSH MARK A III sold 20 Common Stock at $555.46 (~$11.1K)
- · Director WELSH MARK A III sold 50 Common Stock at $556.47 (~$27.8K)
- · Director WELSH MARK A III sold 1 Common Stock at $557.47 (~$557)
03-11-2026
Director Hanson Michael Donn was awarded 238 Common Stock. Hanson Michael Donn holds 695 shares after the transaction.
- · Director Hanson Michael Donn was awarded 238 Common Stock
03-11-2026
Director Budden Joan A was awarded 406 Common Stock at $83.14 (~$33.8K). Budden Joan A holds 2,541 shares after the transaction.
- · Director Budden Joan A was awarded 406 Common Stock at $83.14 (~$33.8K)
03-11-2026
Corp. VP-Global Sales & Mktg. Davies Philip D exercised/converted 3,073 Common Stock at $33.96 (~$104K). 14 transactions reported in total. Davies Philip D holds 1,920 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Corp. VP-Global Sales & Mktg. Davies Philip D exercised/converted 3,073 Common Stock at $33.96 (~$104K)
- · Corp. VP-Global Sales & Mktg. Davies Philip D sold 478 Common Stock at $175.00 (~$83.6K)
- · Corp. VP-Global Sales & Mktg. Davies Philip D sold 100 Common Stock at $176.26 (~$17.6K)
- · Corp. VP-Global Sales & Mktg. Davies Philip D sold 100 Common Stock at $177.32 (~$17.7K)
- · Corp. VP-Global Sales & Mktg. Davies Philip D sold 300 Common Stock at $179.36 (~$53.8K)
- · Corp. VP-Global Sales & Mktg. Davies Philip D sold 200 Common Stock at $180.95 (~$36.2K)
- · Corp. VP-Global Sales & Mktg. Davies Philip D sold 300 Common Stock at $182.89 (~$54.9K)
- · Corp. VP-Global Sales & Mktg. Davies Philip D sold 400 Common Stock at $184.73 (~$73.9K)
03-11-2026
Chief Financial Officer Ard Amy E was awarded 7,268 Class A Common Stock. Ard Amy E holds 69,480 shares after the transaction.
- · Chief Financial Officer Ard Amy E was awarded 7,268 Class A Common Stock
- · Chief Financial Officer Ard Amy E was awarded 18,574 Non-qualified stock options (right-to-buy)
03-11-2026
Director Fish James C Jr bought 1,000 Common Stock at $620.39 (~$620K). Fish James C Jr holds 4,714 shares after the transaction.
- · Director Fish James C Jr bought 1,000 Common Stock at $620.39 (~$620K)
03-11-2026
CSO Greenberg Aaron Samuel sold 276 Ordinary Shares at $48.55 (~$13.4K). Greenberg Aaron Samuel holds 24,872 shares after the transaction.
- · CSO Greenberg Aaron Samuel sold 276 Ordinary Shares at $48.55 (~$13.4K)
03-11-2026
Chief Technology Officer Lackritz Neal Matthew was awarded 4,593 Restricted Stock Units.
- · Chief Technology Officer Lackritz Neal Matthew was awarded 4,593 Restricted Stock Units
03-11-2026
Director FRASCH RONALD sold 15,000 Common Stock at $153.51 (~$2.3M). FRASCH RONALD holds 61,180 shares after the transaction.
- · Director FRASCH RONALD sold 15,000 Common Stock at $153.51 (~$2.3M)
03-11-2026
10% owner Manufacturers Life Insurance Co (Bermuda Branch) bought 756,628.6562 Common Shares of Beneficial Interest at $16.12 (~$12.2M). Manufacturers Life Insurance Co (Bermuda Branch) holds 21,617,951.8471 shares after the transaction.
- · 10% owner Manufacturers Life Insurance Co (Bermuda Branch) bought 756,628.6562 Common Shares of Beneficial Interest at $16.12 (~$12.2M)
03-11-2026
Director McLean Benjamin J. was awarded 654 Phantom Stock Unit at $83.14 (~$54.4K).
- · Director McLean Benjamin J. was awarded 654 Phantom Stock Unit at $83.14 (~$54.4K)
03-11-2026
EVP, Brand President, HEYDUDE Campbell Rupert George sold 2,645 Common Stock at $150.87 (~$399K). Campbell Rupert George holds 68,573 shares after the transaction.
- · EVP, Brand President, HEYDUDE Campbell Rupert George sold 2,645 Common Stock at $150.87 (~$399K)
Get daily alerts with 12 investment signals, 8 risk alerts, 7 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: USA Insider Trading Pulse
🇺🇸 More from United States
View all →November 03, 2026
US Pre-Market SEC Filings Roundup — November 03, 2026
US Pre-Market SEC Filings Roundup
November 03, 2026
US Merger & Acquisition SEC Filings — November 03, 2026
US Merger & Acquisition SEC Filings
November 02, 2026
US Pre-Market SEC Filings Roundup — November 02, 2026
US Pre-Market SEC Filings Roundup
November 02, 2026
Nasdaq 100 Stocks SEC Filings — November 02, 2026
Nasdaq 100 Stocks SEC Filings